Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1999 3
2000 2
2002 3
2003 3
2004 4
2005 3
2006 4
2007 3
2008 3
2009 11
2010 11
2011 14
2012 15
2013 26
2014 64
2015 64
2016 67
2017 60
2018 58
2019 50
2020 36
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25074434

455 results
Results by year
Filters applied: . Clear all
Page 1
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
Farinati F, Vanin V, Giacomin A, Pozzan C, Cillo U, Vitale A, Di Nolfo AM, Del Poggio P, Benvegnu' L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Farinati F, et al. Liver Int. 2015 Jan;35(1):223-31. doi: 10.1111/liv.12649. Epub 2014 Aug 27. Liver Int. 2015. PMID: 25074434
Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
Heng-jun G, Yao-jun Z, Min-shan C, Mei-xian C, Jun-ting H, Li X, Lau WY. Heng-jun G, et al. Liver Int. 2014 Apr;34(4):612-20. doi: 10.1111/liv.12307. Epub 2013 Sep 13. Liver Int. 2014. PMID: 24028297
Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.
Ciria R, López-Cillero P, Gallardo AB, Cabrera J, Pleguezuelo M, Ayllón MD, Luque A, Zurera L, Espejo JJ, Rodríguez-Perálvarez M, Montero JL, de la Mata M, Briceño J. Ciria R, et al. Eur J Surg Oncol. 2015 Sep;41(9):1153-61. doi: 10.1016/j.ejso.2015.05.023. Epub 2015 Jun 12. Eur J Surg Oncol. 2015. PMID: 26118317
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT. Yau T, et al. Gastroenterology. 2014 Jun;146(7):1691-700.e3. doi: 10.1053/j.gastro.2014.02.032. Epub 2014 Feb 25. Gastroenterology. 2014. PMID: 24583061
Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
Ni JY, Kong J, Sun HL, Chen YT, Luo JH, Wang WD, Chen D, Jiang XY, Xu LF. Ni JY, et al. Acad Radiol. 2018 Apr;25(4):423-429. doi: 10.1016/j.acra.2017.10.018. Epub 2017 Nov 29. Acad Radiol. 2018. PMID: 29198946
Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y, Chen B, Liu N, Li N, Dao H, Chen W, Yang J. Huang Y, et al. Int J Clin Pharmacol Ther. 2017 Jun;55(6):498-508. doi: 10.5414/CP202787. Int J Clin Pharmacol Ther. 2017. PMID: 28157070
Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.
Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Dhanasekaran R, et al. HPB (Oxford). 2010 Apr;12(3):174-80. doi: 10.1111/j.1477-2574.2009.00138.x. HPB (Oxford). 2010. PMID: 20590884 Free PMC article.
Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.
Radu P, Groza I, Iancu C, Al Hajjar N, Andreica V, Sparchez Z. Radu P, et al. J Gastrointestin Liver Dis. 2013 Sep;22(3):291-7. J Gastrointestin Liver Dis. 2013. PMID: 24078986 Free article.
Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG. Chen RX, et al. J Gastroenterol Hepatol. 2016 Feb;31(2):442-9. doi: 10.1111/jgh.13077. J Gastroenterol Hepatol. 2016. PMID: 26259976
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Biolato M, Gallusi G, Iavarone M, Cabibbo G, Racco S, De Santis A, Corte CD, Maida M, Attili AF, Sangiovanni A, Cammà C, La Torre G, Gasbarrini A, Grieco A. Biolato M, et al. Ann Hepatol. 2018 January-February;17(1):110-118. doi: 10.5604/01.3001.0010.7542. Ann Hepatol. 2018. PMID: 29311396 Free article.
455 results
Jump to page
Feedback